Search - tctmd.com

Displaying 141 - 160 of 454

Sort: Relevancy | Date

News Daily News

Could an App Replace Statin Prescribing by Doctors?

Michael O'Riordan

September 08, 2021

News Conference News ESC 2021

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

Michael O'Riordan

September 03, 2021

News Conference News ESC 2021

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

Michael O'Riordan

August 31, 2021

News Daily News

Statins Positively Alter Coronary Plaque Composition

Michael O'Riordan

August 23, 2021

News Daily News

Statin Decisions Gain From Scoring of Coronary Artery Calcium: MESA

Yael L. Maxwell

July 21, 2021

News Daily News

Latest Statin Risk-Benefit Analysis: More Harm Than Good?

Yael L. Maxwell

July 15, 2021

News Daily News

ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores

Shelley Wood

July 12, 2021

News Daily News

OMT Boosts Survival in Revascularized Patients at 10 Years

Michael O'Riordan

June 29, 2021

News Daily News

Less Cancer Among HF Patients Taking Statins, Registry Shows

Michael O'Riordan

June 23, 2021

News Daily News

Statins Not Linked to Dementia or Memory Changes: ASPREE

Michael O'Riordan

June 21, 2021

News Daily News

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Michael O'Riordan

June 16, 2021

News Daily News

It Pays to Reward Doctors for Risk-Stratifying Patients, Early Data Hint

L.A. McKeown

June 04, 2021

News Conference News EAS 2021

For High-Risk Patients Getting Evolocumab in Europe, Other Meds Fall Short

Michael O'Riordan

June 03, 2021

News Daily News

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

Michael O'Riordan

April 21, 2021

News Daily News

FDA Approves Evinacumab for Rare Homozygous FH

Michael O'Riordan

February 11, 2021

News Daily News

Afternoon Blahs? Statin Prescriptions More Likely for Early-Day Patients

Michael O'Riordan

February 01, 2021

News Daily News

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

Michael O'Riordan

January 14, 2021

News Daily News

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Michael O'Riordan

December 11, 2020

News Daily News

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

Michael O'Riordan

November 26, 2020

News Conference News AHA 2020

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

Michael O'Riordan

November 15, 2020

Advertisement

Could an App Replace Statin Prescribing by Doctors?

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

Statins Positively Alter Coronary Plaque Composition

Statin Decisions Gain From Scoring of Coronary Artery Calcium: MESA

Latest Statin Risk-Benefit Analysis: More Harm Than Good?

ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores

OMT Boosts Survival in Revascularized Patients at 10 Years

Less Cancer Among HF Patients Taking Statins, Registry Shows

Statins Not Linked to Dementia or Memory Changes: ASPREE

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

It Pays to Reward Doctors for Risk-Stratifying Patients, Early Data Hint

For High-Risk Patients Getting Evolocumab in Europe, Other Meds Fall Short

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

FDA Approves Evinacumab for Rare Homozygous FH

Afternoon Blahs? Statin Prescriptions More Likely for Early-Day Patients

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content